Stock listing
MRNA Stock Price, News, Filings & Events — Moderna, Inc.
Selected listing: MRNA · BMV · MXN · MX
This page tracks Moderna, Inc.'s MRNA:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRNA:BMV. MRNA:BMV is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moderna, Inc. is a public company traded under the ticker MRNA in the American market. The company has a market capitalization of approximately $24.53 billion. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.
- Ticker
- MRNA:BMV
- Asset type
- Stock
- Market cap
- $55.09B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
Moderna, Inc. MRNA:BMV stock context
This page tracks Moderna, Inc.'s MRNA:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRNA:BMV. MRNA:BMV is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moderna, Inc. is a public company traded under the ticker MRNA in the American market. The company has a market capitalization of approximately $24.53 billion. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.
Latest news from Moderna, Inc.
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
August 28, 2026
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
August 27, 2026
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
August 27, 2026
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
August 5, 2026
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
August 4, 2026
Moderna, Inc. earnings calls
Moderna, Inc. (MRNA) Q2 2026 Earnings Call
July 31, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2026 Earnings Call
May 1, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q4 2025 Earnings Call
February 13, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q2 2025 Earnings Call
August 1, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Moderna, Inc.
Moderna, Inc. investor report
Review AI stock analysis and investor report context for MRNA:BMV.
Moderna, Inc. company profile
View the public company page for Moderna, Inc. on 6ix.
Moderna, Inc. news
Read company news and market updates connected to Moderna, Inc..
Moderna, Inc. investor events
Find investor webinars, events, and replay context for Moderna, Inc..
Alternate listings
MRNA:NASDAQ
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
0QF:GETTEX
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
1MRNA:MIL
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
0QF:XETR
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
0QF:TRADEGATE
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
MRNA:BCBA
AR · ARS
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
A2N9D9:LSX
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
M1RN34:BMFBOVESPA
BR · BRL
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
MRNA:BOATS
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
4MRNA:EUROTLX
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
A2N9D9:LS
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.
0A45:LSIN
GB · USD
Alternate listing for Moderna, Inc.; the primary context on this page is MRNA:BMV.